Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Sep 24 | ANAB AnaptysBio | Common Stock | Option exercise | Acquire M | No | No | 0 | 1,300 | 0.00 | 3,335 |
15 Sep 24 | ANAB AnaptysBio | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 1,300 | 0.00 | 2,600 |
15 Jun 24 | ANAB AnaptysBio | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,035 | 0.00 | 2,035 |
15 Jun 24 | ANAB AnaptysBio | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,035 | 0.00 | 0 |
4 Jun 24 | CRGX CARGO Therapeutics, Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 19.17 | 23,742 | 455.13 k | 23,742 |
8 May 24 | TVTX Travere Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 6,500 | 0.00 | 28,875 |
8 May 24 | TVTX Travere Therapeutics | Stock option Common Stock | Grant | Acquire A | No | No | 6.82 | 19,500 | 132.99 k | 19,500 |
11 Apr 24 | BCEL Atreca Inc - Ordinary Shares | Series A Junior Preferred Stock | Buy | Acquire P | No | No | 0.01 | 1 | 0.01 | 1 |